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Abstract
Background: The translocation of neuronal nitric oxide synthase (nNOS) from the cytosol to the
membrane is functionally coupled to the activation of N-methyl-D-aspartate (NMDA) receptors at
synapses. Whereas there is abundant evidence indicating that ATP and nitric oxide are involved in
nociceptive transmission, whether nNOS is activated by ATP remains unknown. We recently
established a fluorescence imaging system for examining nNOS translocation in PC12 cells
expressing a yellow fluorescence protein-tagged nNOS N-terminal mutant, nNOSNT-YFP, and
examined the effect of ATP on nNOS translocation using the system.
Results: The translocation of nNOS was induced by ATP in the presence of NMDA and forskolin,
an adenylate cyclase activator. The purinergic P2X receptor agonist 2-MeSATP and the P2Y agonist
UTP significantly enhanced nNOS translocation; and simultaneous stimulation with 2-MeSATP and
UTP exhibited the same concentration-response curve for the translocation as obtained with ATP.
ATP, 2-MeSATP, and UTP increased the intracellular Ca2+ concentration ([Ca2+]i) in PC12 cells.
Conversely, whereas the P2X receptor antagonist PPADS and the P2Y antagonist reactive blue-2
partially inhibited increases in the translocation of nNOS and [Ca2+]i by ATP, the non-selective P2
receptor antagonist suramin completely blocked them. In addition, the increase in the nNOS
translocation by ATP was blocked by NMDA receptor antagonists and inhibitors of protein kinase
A, protein kinase C, and Src kinase. Consistent with the expression of P2X and P2Y receptors in
the spinal cord, ATP and UTP increased the [Ca2+]i in primary cultured spinal neurons. ATP
potentiated and prolonged the [Ca2+]i increase produced by NMDA in the dorsal horn of the spinal
cord. Furthermore, the selective P2X3/P2X2/3 antagonist A-317491 inhibited nNOS activation
assessed by NO formation in spinal slices prepared from neuropathic pain model mice.
Conclusion: ATP is involved in nNOS translocation mediated by protein kinase C via activation
of P2X and P2Y receptors and nNOS translocation may be an action mechanism of ATP in
nocieptive processing in the spinal cord.
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Background
Adenine and uridine nucleotides are present in tissues and
released from all different types of cells in the nervous sys-
tem as well as from damaged tissues in the periphery
under pathophysiological conditions. The released nucle-
otides are implicated in diverse sensory processes includ-
ing pain transmission via purinergic P2X and P2Y
receptors [1,2]. To date 7 ionotropic P2X receptors [3] and
8 G-protein-coupled metabotropic P2Y receptors [4] have
been cloned, and most of them are expressed on primary
afferent neurons or spinal dorsal horn neurons. Exoge-
nous administration of ATP and P2X-receptor agonists
into the hind paw caused short-lasting nocifensor behav-
iors and thermal hyperalgesia [5,6], as well as relatively
long-lasting mechanical allodynia [7], in rodents. On the
other hand, P2 antagonists including A-317491, a selec-
tive P2X3/P2X2/3-receptor antagonist decreased various
nociceptive behaviors, inflammatory hyperalgesia, and
neuropathic pain [8-11]. P2X3-deficient mice have
reduced pain-related behaviors in the formalin test [12].
Tsuda et al. also reported that the increased expression of
P2X4-receptors induced by nerve injury or ATP stimula-
tion in the spinal microglia produced allodynia [13].
In the central nervous system, nitric oxide (NO) is pro-
duced by neuronal NO synthase (nNOS) following the
influx of Ca2+ through  N-methyl-D-aspartate (NMDA)
receptors [14-16], and has been implicated in synaptic
plasticity such as central sensitization in the spinal cord
[17,18]. Co-localization of nNOS with NMDA receptors
at the postsynaptic density (PSD) suggests that NMDA-
receptor activity may be coupled to nNOS activation by a
close spatial interaction [19]. We recently showed that the
increase in nNOS activity in the superficial dorsal horn of
the spinal cord reflects a neuropathic pain state even 1
week after nerve injury [20] and that this nNOS activation
may be reversibly regulated by the translocation of nNOS
from the cytosol to the plasma membrane in the presence
of NMDA and the neuropeptide pituitary adenylate
cyclase-activating polypeptide (PACAP) [21]. Unlike
endothelial and inducible NOSs that anchor to the mem-
brane by lipid modification, nNOS is unique in having an
~ 250 a.a. N-terminal extension containing a PSD-95/disc
large/zonula occludens-1 (PDZ) domain and is recruited
to membranes via protein-protein interactions [15,16].
We recently constructed a yellow fluorescence protein
(YFP)-tagged nNOS N-terminal mutant encompassing
amino acid residues 1–299 (nNOSNT-YFP) and suc-
ceeded in visualizing its translocation by co-stimulation
with NMDA and PACAP in PC12 cells stably expressing it
[22]. Thereby we demonstrated that PACAP was involved
in nNOS translocation through the activation of both pro-
tein kinase C (PKC) following calcium mobilization and
protein kinase A (PKA) mediated by PACAP receptor 1.
ATP acts as an excitatory neurotransmitter in the dorsal
horn of the spinal cord [23]. The activation of P2X recep-
tors not only mediates but also facilitates excitatory trans-
mission, releasing glutamate from primary afferent fibers
in the spinal cord [24,25]. In the present study, we dem-
onstrated that ATP could translocate nNOS from the
cytosol to the plasma membrane mediated by PKC via
activation of P2X and P2Y receptors in the presence of
NMDA and forskolin, an adenylate cyclase activator, by
using a fluorescence imaging system.
Methods
Materials
PC12 cells and PC12 cells stably expressing nNOSNT-YFP
(PC12N cells) were maintained in Dulbecco's modified
Eagle medium (DMEM) supplemented with 5% fetal calf
serum, 10% horse serum, 50 U/ml penicillin, and 50 μg/
ml streptomycin at 37°C in a 5% CO2 atmosphere. The
chemicals used and their sources were as follow: NMDA,
MK-801, 2-amino-5-phosphonovaleric acid (APV), cal-
phostin C, PP2, suramin, pyridoxal-phosphate-6-azophe-
nyl-2',4'-sulfonic acid (PPADS), 2-(methylthio)
adenosine 5'-triphosphate (2-MeSATP), 2-(4-morpholi-
nyl)-8-phenyl-4H-1-benzopyran- 4-one (LY294002), 2-
(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
(PD98059), reactive blue-2 (RB-2), A-317491, 4-(4-fluor-
ophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-
imidazole (SB203580), cytosine β-D-arabinofuranoside
(Ara-C), Dnase I, and 8-bromo-cAMP (8-Br-cAMP) from
Sigma (St. Louis, MO, USA); 8-Br-cGMP from Calbio-
chem (La Jolla, CA, USA); nerve growth factor (NGF), ros-
covitine, and UTP from Wako Pure Chemicals (Osaka,
Japan); ATP from Oriental Yeast Co. (Tokyo, Japan); 1-[N,
O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-
phenylpiperazine (KN-62) and N-[2-(4-bromocin-
namylamino)-ethyl]-5-isoquinoline (H-89) from Seika-
gaku Kogyo (Tokyo, Japan); fura-2 acetoxymethyl ester
and  NG-nitro-L-arginine methyl ester (L-NAME) from
Dojindo (Kumamoto, Japan); diaminorhodamine-4M
acetoxymethyl ester (DAR-4M AM) from Daiichi Pure
Chemicals (Tokyo, Japan); and PACAP from Peptide Insti-
tute (Osaka, Japan). Other chemicals were of reagent
grade.
Male ddY mice were purchased from Shizuoka Laboratory
Centre (Hamamatsu, Japan). The animals were housed
under conditions of a 12-h light-darkness cycle, a constant
temperature of 22 ± 2°C and 60 ± 10% humidity. They
were allowed free access to food and water before testing.
All animal experiments were carried out in accordance
with the National Institutes of Health guide for the care
and use of laboratory animals and were approved by the
Animal Experimentation Committee of Kansai Medical
University.Molecular Pain 2009, 5:40 http://www.molecularpain.com/content/5/1/40
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nNOSNT-YFP translocation assay
PC12N cells were plated on poly-L-lysine-coated glass-
bottomed 35-mm dishes at a density of 1 × 104 cells/cm2
and caused to differentiate by 5-day treatment with 50 ng/
ml NGF. Translocation of nNOSNT-YFP was examined in
the cells essentially as reported previously [22]. Briefly,
after a 30-min incubation with test agents, the cells were
rinsed with phosphate-buffered saline, fixed with 4%
paraformaldehyde in 0.12 M sodium phosphate buffer,
pH 7.4, for 20 min at room temperature, and then rinsed
with phosphate-buffered saline. Digital images were cap-
tured on a Zeiss LSM510 laser-scanning confocal micro-
scope (Oberkochen, Germany). The intensity of
nNOSNT-YFP fluorescence was quantified by using
ImageJ. To evaluate the translocation of nNOSNT-YFP to
the plasma membrane in PC12N cells, we counted the
number of cells possessing foci of nNOSNT-YFP on their
plasma membrane and expressed this number as a per-
centage of the total cells examined. More than 40 cells
were observed for each datum point, and at least 4 exper-
iments were carried out in each analysis.
Primary culture
The isolation and primary culture of neurons were pre-
pared from the spinal cord of E13-E15 ddY mice. Briefly,
after the pregnant animals had been anesthetized with
isoflurane, the spinal cords below the cervical segment
were collected from embryos under sterile technique and
placed in ice-cold phosphate-buffered saline containing
0.1% glucose. The spinal cords were minced with scissors
in 5 ml of DMEM containing 0.5 mg/ml of trypsin and
kept at 37°C for 30 min. After incubation, 5 ml of DMEM
containing 10% fetal calf serum, 40 ng/ml gentamicin,
and 50 μl DNase I were added. The cell pellet was sus-
pended in 5 ml of DMEM containing 10% fetal calf serum
and 40 ng/ml gentamicin, filtrated and centrifuged for 5
min at 1000 rpm. After washing the cell pellet twice, the
spinal neurons were plated on 35-mm dishes at 1 × 105
cells/ml. The cells were kept in DMEM containing 10%
fetal calf serum, 20 ng/ml NGF, 40 ng/ml gentamicin and
10 μM Ara-C at 37°C in a CO2 incubator for 24 h, replaced
with fresh media without Ara-C, and cultured for 3–7 days
until use.
Measurement of intracellular free Ca2+ concentration 
([Ca2+]i) and cAMP content
Changes in [Ca2+]i in NGF-differentiated PC12 cells, spi-
nal neurons and spinal slices were measured as described
previously [21,22]. After the cells had been incubated
with 5 μM fura-2acetoxymethyl ester for 30 min in DMEM
containing 5% fetal calf serum and 10% horse serum, the
fura-2-loaded cells on an inverted fluorescence micro-
scope (Olympus IX-70, Tokyo, Japan) were stimulated
with ATP, 2-MeSATP or UTP in HEPES-buffered saline
solution (HBS) or in Ca2+-free HBS supplemented with 6
mM EGTA at 2–3 ml/min. The cells were excited at 340
and 380 nm and the fluorescence emission signal was
monitored by using an Aquacosmos-Ratio imaging sys-
tem (Hamamatsu Photonics, Hamamatsu, Japan) with a
cooled charge-coupled device camera. [Ca2+]i was
expressed as a ratio of fluorescence emission intensity at
340 and 380 nm. For the measurement of [Ca2+]i changes
in spinal slices, lumbosacral segments prepared from 7-
14-day-old ddY mice were cut using a vibrating blade
microtome (VT-1000S; Leica, Nussloch, Germany), and
slices were incubated for 2 h in artificial cerebrospinal
fluid bubbled with 95% O2 and 5% CO2 at 37°C. The
slices (350-μm thick) thus obtained from lumbar seg-
ments L4-L6 were used for [Ca2+]i measurements.
For measurement of cAMP contents, NGF-differentiated
PC12 cells were incubated for 15 min with test agents in
HBS containing 0.5 mM 3-iso-butyl-1-methylxanthine,
and intracellular cAMP levels were determined by use of a
cAMP radioimmunoassay kit (GE Healthcare, Piscataway,
NJ, USA).
Measurement of NO in spinal slices
Neuropathic pain mode was prepared by left L5 spinal
nerve transection of 3-week-old ddY mice and slices were
prepared from the lumbar spinal cord of the neuropathic
pain model mice 7 days after operation as described pre-
viously [20]. After a 2-h incubation of the slices in artifi-
cial cerebrospinal fluid containing 1 mM L-NAME
bubbled with 95% O2/5% CO2 at 37°C, slices were incu-
bated in artificial cerebrospinal fluid containing 10 μM
DAR-4M AM and 1 mM L-NAME for 2 h at room temper-
ature. The slices were kept in a Krebs solution containing
1 mM L-NAME for more than 1 h after loading, and then
were placed in the recording chamber. NO generation in
spinal slices was started by replacement of 1 mM L-NAME
with 1 mM arginine in a Krebs superfusion buffer equili-
brated with 95% O2/5% CO2. The slices were excited at
540 ± 10 nm and the fluorescence emission signal with a
>590-nm long-pass filter was monitored by using the
Aquacosmos-Ratio imaging system. Increase in NO for-
mation in the spinal cord was expressed as the ratio of flu-
orescence intensity of DAR-4M to that prior to treatment.
Reverse transcriptase-polymerase chain reaction (RT-
PCR)
Total RNAs were isolated from NGF-treated or untreated
PC12N cells and the spinal cord with TRIzol reagent (Inv-
itrogen-Life Technol., Carlsbad, CA, USA), and the first-
strand cDNA was synthesized from 1 μg of total RNA by
using a ReverTra Ace-α kit (Toyobo, Osaka, Japan). PCR
reactions were carried out in a total 25 μl of PCR buffer
containing 1.25 units of GeneTaq DNA polymerase (Nip-
pon Gene, Tokyo, Japan), 1.5 mM MgCl2, 200 μM concen-
tration of each deoxynucleoside triphosphate, and 0.4Molecular Pain 2009, 5:40 http://www.molecularpain.com/content/5/1/40
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mM specific oligonucleotide primers defined in Table 1.
The PCR conditions consisted of an initial denaturation at
94°C for 3 min, followed by 25 cycles (β-actin) or 40
cycles (the other genes) of amplification (94°C for 1 min,
and 65°C for 1 min and 72°C for 1 min), and ending with
a final 5-min extension at 72°C. PCR products were sepa-
rated on 2% agarose gels in Tris-acetate-EDTA buffer,
stained with ethidium bromide, visualized under ultravi-
olet light, and photographed.
Statistics
All data were presented as the mean ± SEM. Statistical
analyses of the results were made by using Student's t test
or the Mann-Whitney U test. EC50 values were calculated
by use of the computer program for graded responses (ver
1.2) http://chiryo.phar.nagoya-cu.ac.jp/javastat/
Graded50-j.htm.
Results
Translocation of nNOS from the cytosol to the plasma 
membrane by ATP
We recently succeeded in visualizing nNOS translocation
from the cytosol to the plasma membrane in PC12N cells
stably expressing nNOSNT-YFP and demonstrated that
the translocation is mediated by activation of PKA and
PKC in the presence of NMDA [22]. Since ATP is known
to release glutamate from primary afferent fibers and also
to act as an excitatory transmitter in the dorsal horn of the
spinal cord, we examined whether ATP could cause the
translocation of nNOSNT-YFP in PC12N cells. Although
the formation of nNOSNT-YFP foci was observed on the
plasma membrane of about 10% of the NGF-differenti-
ated PC12N cells, nNOSNT-YFP was exclusively observed
in the cytosol of most cells in the microscopic field. When
NGF-differentiated PC12N cells were simultaneously
treated for 30 min with 100 μM ATP, 100 μM NMDA, and
10  μM forskolin, an adenylate cyclase activator, the
number of the cells microscopically showing the foci of
yellow fluorescence of nNOSNT-YFP on the plasma mem-
brane apparently increased. Figure 1A presents such cells
without and with foci after the treatment. As compared
with that along the line "i-ii " the fluorescence intensity
along the line "iii-iv" (lower panel in Figure 1A) clearly
showed that the foci of nNOSNT-YFP were located on the
plasma membrane. When the cells showing the foci were
counted as being positive for the nNOSNT-YFP transloca-
tion to the plasma membrane, the translocation was sig-
nificantly enhanced by simultaneous stimulation with
100 μM ATP, 100 μM NMDA, and 10 μM forskolin (22.5
± 1.64% vs. 11.6 ± 0.40% of the cells without stimulation,
*p < 0.05), but not with NMDA, forskolin, and ATP alone
or in any other combinations (Figure 1B). These results
suggest that ATP would induce the nNOS translocation in
PC12N cells in the presence of NMDA and forskolin.
Involvement of P2 and NMDA receptors in nNOS 
translocation by ATP
To clarify the involvement of activation of purinergic P2
receptors in the enhancement of nNOSNT-YFP transloca-
tion by ATP in the presence of NMDA and forskolin, we
first examined the effect of P2 receptor antagonists on the
translocation in PC12N cells (Figure 2). The non-selective
P2 receptor antagonist suramin at 250 μM (11.96 ±
0.82%, #p < 0.05) completely abolished the nNOSNT-YFP
translocation enhanced by NMDA, forskolin, and ATP
(23.19 ± 0.77%, *p < 0.05 compared with control). This
enhanced translocation of nNOSNT-YFP was also signifi-
cantly inhibited by the P2X receptor antagonist PPADS
Table 1: Primer sequences employed for RT-PCR analysis
Gene Primer sequences (5' to 3') Product length (bp)
P2X1 (forward) TGATCTGGACTGGCACGTTC 441
P2X1 (reverse) GGTCCTCATGTTCTCCTGCA
P2X3 (forward) TGGCG TTCTG GGTAT TAAGA TCGG 743
P2X3 (reverse) CAGTG GCCTG GTCAC TGGCG A
P2X4 (forward) GAGGC ATCAT GGGTA TCCAG ATCAA G 447
P2X4 (reverse) GAGCG GGGTG GAAAT GTAAC TTTAG
P2X6 (forward) CGATT CACTC TCCAG TCCG 317
P2X6 (reverse) GGTCC TCCAG TAGAA ACCG
P2Y2 (forward) CGCTT CAACG AGGAC TTCA 589
P2Y2 (reverse) CCATG AGCAC GTAAC AGAC
P2Y4 (forward) GTTGC CTATG AGCTA TGCAG 518
P2Y4 (reverse) ACCAT GACTG CCGAA CTGAA
P2Y6 (forward) GGAGA CCTTG CCTGC CGCCT GGTA 410
P2Y6 (reverse) TACCA CGACA GCCAT ACGGG CCGC
β-actin (forward) TTCTA CAATG AGCTG CGTGT GGC 456
β-actin (reverse) CTC(A/G)T AGCTC TTCTC CAGGG AGGA 982
G3PDH (forward) TGAAGGTCGGTGTGAACGGATTTGGC
G3PDH (reverse) CATGTAGGCCATGAGGTCCACCACMolecular Pain 2009, 5:40 http://www.molecularpain.com/content/5/1/40
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(15.33 ± 0.54%, #p < 0.05) and the P2Y receptor antago-
nist RB-2 (15.11 ± 1.36%, #p < 0.05) at 100 μM. However,
the inhibitory effects of both PPADS and RB-2 were only
partial; and the translocation remained significantly
enhanced as compared with that for the vehicle control.
To examine whether the activation of NMDA receptors
was involved in the nNOSNT-YFP translocation with ATP
in the presence of NMDA and forskolin, we next exam-
ined the effect of NMDA receptor antagonists on nNOS
translocation in PC12N cells (Figure 2). The increase in
the translocation was completely blocked by NMDA
receptor antagonists MK-801 and APV. These results dem-
onstrate that the activation of both P2 and NMDA recep-
tors was required for the nNOS translocation by ATP in
the presence of NMDA and forskolin.
Involvement of P2X receptors or P2Y receptors in nNOS 
translocation by ATP
Conversely we tested the effect of P2 receptor agonists on
the translocation of nNOSNT-YFP to the plasma mem-
brane in PC12N cells in the presence of NMDA and for-
skolin (Figure 3A). The translocation of nNOSNT-YFP was
increased from 12.1 ± 0.98% to 19.7 ± 0.88% by 100 μM
2-MeSATP, a P2X receptor agonist, and to 19.6 ± 2.16% by
100 μM UTP, a P2Y receptor agonist. These results suggest
that the translocation of nNOSNT-YFP in PC12N cells was
induced by the activation of either P2X receptors or P2Y
receptors. Figure 3B shows the concentration-response
Figure 1
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Translocation of nNOSNT-YFP by ATP in PC12N cells Figure 1
Translocation of nNOSNT-YFP by ATP in PC12N 
cells. A. Expression and translocation of nNOSNT-YFP in a 
PC12N cell. After a 30-min incubation of NGF-differentiated 
PC12N cells with 100 μM ATP, 100 μM NMDA, and 10 μM 
forskolin (FK), the cells were fixed; and then fluorescent 
images of the cells without (left) and with (right) foci were 
acquired by a confocal microscope. Insets in "A" depict 
higher magnification of the cells delineated by rectangles. The 
fluorescence intensity of nNOSNT-YFP was quantified along 
the indicated lines by using ImageJ. In these digital images, 
points "i-ii" and "iii-iv" represent the edges of the cells. B. 
Involvement of ATP in nNOSNT-YFP translocation in 
PC12N cells. After a 30-min incubation of NGF-differenti-
ated PC12N cells with the indicated combinations of 100 μM 
ATP, 100 μM NMDA, and/or 10 μM FK, the translocation 
was calculated as described under "Methods." About 40 cells 
in a 35-mm glass-bottomed dish were examined in each 
translocation assay by using a confocal microscope; and the 
cells showing foci of yellow fluorescence of nNOSNT-YFP 
on the plasma membrane, as shown in "A," were considered 
to be positive for nNOS translocation. Data are presented as 
the mean ± SEM of four translocation assays. *p < 0.05 com-
pared with vehicle.Molecular Pain 2009, 5:40 http://www.molecularpain.com/content/5/1/40
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Involvement of purinergic and NMDA receptors in ATP- induced nNOSNT-YFP translocation in PC12N cells Figure 2
Involvement of purinergic and NMDA receptors in 
ATP-induced nNOSNT-YFP translocation in PC12N 
cells. After a 30-min incubation of NGF-differentiated 
PC12N cells without or with 100 μM NMDA, 10 μM forsko-
lin (FK), and 100 μM ATP in the absence and presence of 250 
μM suramin, 100 μM PPADS, 100 μM RB-2, 100 μM MK-801 
or 100 μM APV, the translocation of nNOSNT-YFP was 
observed by confocal microscopy and quantified as described 
in the legend for Figure 1B. Data are presented as the mean 
± SEM (n = 4). *p < 0.05 compared with vehicle; #p < 0.05 
compared with NMDA, FK, and ATP.
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curves of ATP, 2-MeSATP, and UTP for nNOSNT-YFP
translocation in the cells. The translocation of nNOSNT-
YFP was observed at and above 50 μM ATP and reached a
plateau at 100 μM. On the other hand, the translocation
of nNOSNT-YFP started to increase with 2-MeSATP or
UTP at 50 μM but the potencies of the nNOSNT-YFP
translocation by 2-MeSATP and UTP were lower than that
by ATP with EC50 values of 27 and 25 μM, respectively.
However, the co-stimulation with 2-MeSATP and UTP
showed almost the same concentration curve for the
translocation of nNOSNT-YFP as that obtained with ATP
stimulation. Since 2-MeSATP and UTP are the respective
agonists of P2X and P2Y receptors, these results demon-
strate that the translocation of nNOSNT-YFP to the
plasma membrane by ATP was additively mediated by
activation of P2X and P2Y receptors.Signal transduction
coupled to ATP and involved in nNOS translocation
Since both P2X and P2Y receptors are known to increase
[Ca2+]i, to clarify signaling pathways involved in nNOS
translocation by ATP, we next examined the increase in
[Ca2+]i by ATP and its analogues in fura-2-loaded PC12
cells (Figure 4A). ATP increased [Ca2+]i in a concentra-
tion-dependent manner with an EC50 value of 3.5 μM. 2-
MeSATP and UTP also increased [Ca2+]i, giving EC50 val-
ues of 11.8 and 2.8 μM, respectively. P2X receptors are ion
channels and P2Y receptors are G-protein-coupled recep-
tors. Next we examined the ATP-induced increase in
[Ca2+]i in Ca2+-free perfusion buffer supplemented with 6
mM EGTA, a Ca2+ chelating reagent (Figure 4B). Although
ATP could increase the [Ca2+]i in the PC12 cells in the
presence of EGTA, the peak level of the increase caused by
ATP was lower in the presence of EGTA than in the
absence of it, and the concentration-response curve with
ATP and EGTA was similar to that obtained with UTP. As
the P2 receptor antagonists inhibited the translocation of
nNOSNT-YFP to the plasma membrane (Figure 2), we
next investigated the effect of P2 receptor antagonists on
the increase in [Ca2+]i caused by 100 μM ATP (Figure 4C).
At 1 mM the non-selective P2 receptor antagonist suramin
completely suppressed the ATP-induced increase in
[Ca2+]i, but PPADS and RB-2 at the same concentration
only partially reduced it. These results are consistent with
the additive effect on nNOS translocation by P2X and P2Y
agonists (Figure 3B).
Since PACAP increases intracellular cAMP levels as well as
[Ca2+]i via PACAP receptor 1 and induces nNOSNT-YFP
translocation in PC12N cells [22], next we measured
intracellular cAMP levels 15 min after in the presence of
0.5 mM iso-butyl-1-methylxanthine, a phosphodiesterase
inhibitor. Whereas PACAP significantly stimulated the
intracellular cAMP production, ATP only slightly
increased it; and NMDA did not produce cAMP in the
PC12 cells (Figure 5A). Since ATP did not promote the
production of cAMP, we next examined the necessity of
cAMP production in the translocation of nNOSNT-YFP.
We tested the effect of 8-Br-cAMP, a membrane-permea-
ble analog of cAMP, on the translocation of nNOSNT-YFP
(Figure 5B). 8-Br-cAMP increased the nNOSNT-YFP trans-
location to the plasma membrane (21.8 ± 0.98% vs. 11.4
± 0.55% with vehicle, *p < 0.05); but 8-Br-cGMP, a mem-
brane-permeable analog of cGMP, failed to stimulate it
(13.7 ± 1.24%). These results are consistent with our pre-
vious finding that the cAMP/PKA pathway is required for
the translocation of nNOSNT-YFP in PC12N cells.
Signaling pathways involved in nNOS translocation by ATP 
in PC12N cells
To clarify the signal pathways involved in nNOSNT-YFP
translocation induced by ATP in the presence of NMDA
and forskolin, we examined the effects of various inhibi-
tors of protein kinases that can be activated by ATP. Simi-
lar to the other sets of translocation experiments, the
translocation of nNOSNT-YFP was induced with 100 μM
ATP, 100 μM NMDA, and 10 μM forskolin. The PKC
inhibitor calphostin C (12.6 ± 0.90%, #p < 0.05), the Src
inhibitor PP2 (11.8 ± 0.93%, #p < 0.05), and the PKA
inhibitor H-89 (11.1 ± 1.48%, #p < 0.05) inhibited the
translocation of nNOSNT-YFP; whereas KN-62, an inhib-
itor of Ca2+/calmodulin-dependent protein kinase II
failed to inhibit it (Figure 6A).
To further clarify the signal pathways involved in the
translocation in PC12N cells, we examined the effect of
other kinase inhibitors, LY294002 (phosphatidylinositol
3-kinase), PD98059 (extracellular signal-regulated
kinase), SB203580 (p38 mitogen-activated protein
Effect of P2X and P2Y receptor agonists on nNOSNT-YFP  translocation in PC12N cells Figure 3
Effect of P2X and P2Y receptor agonists on 
nNOSNT-YFP translocation in PC12N cells. A. Stimu-
lation of the translocation of nNOSNT-YFP by P2X and P2Y 
receptor agonists. After a 30-min incubation of NGF-differ-
entiated PC12N cells without and with 100 μM 2MeSATP, 
UTP or ATP in the presence of 10 μM forskolin (FK) and 100 
μM NMDA, the translocation of nNOSNT-YFP was deter-
mined by confocal microscopy as described in the legend for 
Figure 1B. Data are presented as the mean ± SEM (n = 4). *p 
< 0.05 compared with vehicle; #p < 0.05 compared with 
NMDA, FK, and ATP. B. Concentration dependency of ATP 
and its analogs for the translocation of nNOSNT-YFP in 
PC12N cells. NGF-differentiated PC12N cells were incu-
bated for 30 min with the indicated concentrations of ATP 
(), 2-MeSATP (■), UTP (▲) or UTP + 2-MeSATP (❍) in 
the presence of 10 μM FK and 100 μM NMDA. Data are pre-
sented as the mean ± SEM (n = 4). *p < 0.05 ATP vs. 2-
MeSATP; #p < 0.05 ATP vs. UTP.Molecular Pain 2009, 5:40 http://www.molecularpain.com/content/5/1/40
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kinase), and roscovitine (cyclin-dependent kinase 5) on
the translocation of nNOSNT-YFP induced by ATP,
NMDA, and forskolin (Figure 6B). None of them signifi-
cantly attenuated the translocation. These results con-
firmed our recent findings [22], demonstrating that nNOS
translocation is mediated by activation of PKA, PKC, and
Src kinase in PC12 cells.
Expression of P2X and P2Y receptors in PC12N cells and 
spinal cord
To date 7 ionotropic P2X receptors and 8 G-protein-cou-
pled metabotropic P2Y receptors have been cloned, and
most of them are expressed on primary afferent neurons
or spinal dorsal horn neurons. So next we examined the
expression of P2X and P2Y subtypes in NGF-undifferenti-
ated or differentiated PC12N cells and the spinal cord by
RT-PCR (Figure 7). In undifferentiated PC12 cells, bands
corresponding to mRNAs for P2X1, P2X3, P2X4 receptors
were detected with the expected sizes. In NGF-differenti-
ated PC12N cells, the same transcripts were present; and,
in addition, P2X6 receptor mRNA was detected. P2Y2,
P2Y4, P2Y6, and P2Y12 receptor mRNAs were also present
in both undifferentiated and NGF-differentiated PC12N
cells. These results are consistent with those of a previous
study [26]. These transcripts of P2X and P2Y receptors
were detected in the spinal cord. These results suggest that
ATP may induce nNOS translocation in the spinal cord as
well as in PC12N cells.
Characterization of [Ca2+]i responses to ATP and UTP in 
cultured spinal neurons
We next examined whether ATP and UTP could increase
[Ca2+]i in primary cultured spinal neurons (Figure 8A).
[Ca2+]i increase of the fura-2-loaded neurons was
Figure 4
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Effect of ATP and ATP analogues on intracellular Ca2+ con- centration ([Ca2+]i) in PC12 cells Figure 4
Effect of ATP and ATP analogues on intracellular 
Ca2+ concentration ([Ca2+]i) in PC12 cells. A. Concen-
tration dependency of [Ca2+]i increase elicited by ATP or 
ATP analogues in NGF-differentiated PC12 cells. Fura-2-
loaded PC12 cells were stimulated with the indicated con-
centrations of ATP (), 2-MeSATP (■) or UTP (▲) in HBS, 
after which the change in [Ca2+]i was measured as a fluores-
cence ratio obtained with excitation at 340 and 380 nm, as 
described under "Methods." B. Effect of extracellular Ca2+ on 
ATP-induced [Ca2+]i increase. Fura-2-loaded PC12 cells were 
stimulated with the indicated concentrations of ATP in HBS 
() or in Ca2+-free HBS supplemented with 6 mM EGTA 
(▲). *p < 0.05 compared with HBS. C. Effect of P2 receptor 
antagonists on ATP-induced [Ca2+]i increase. Fura-2-loaded 
PC12 cells were stimulated with 100 μM ATP in the pres-
ence of the indicated concentrations of suramin (), PPADS 
(❍) or RB-2 (▲). Data are presented as the mean ± SEM (n 
= 30–60). *p < 0.05 compared with PPADS or RB-2.Molecular Pain 2009, 5:40 http://www.molecularpain.com/content/5/1/40
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observed by the treatment with 1 μM ATP (Figure 8B and
8C). The time course and magnitude of [Ca2+]i increase
varied from cell to cell in primary cultured spinal neurons.
Representative traces of [Ca2+]i change from a single cell
showed both phasic and tonic patterns by either ATP (Fig-
ure 8D) or UTP (Figure 8E). The peak level of [Ca2+]i
increase evoked by ATP and UTP also varied among cells
(Figure 8F and 8G) and about 10% of the cells did not
respond to ATP and UTP at 100 μM. Whereas both ATP
and UTP increased [Ca2+]i in spinal neurons in a concen-
tration-dependent manner up to 100 μM, ATP was more
potent in elevating [Ca2+]i than UTP (Figure 9A). When
we examined the effect of P2 receptor antagonists on ATP-
evoked [Ca2+]i increase in spinal neurons, A-317491, a
selective P2X3/P2X2/3  antagonist, RB-2, and suramin
reduced the increase in 6.8, 41, and 78% of the cells
responsive to 1 μM ATP, respectively (Figure 9B).
To further clarify whether nNOS was activated by ATP in
the spinal cord, we prepared 10 spinal slices from 5 wild-
type mice and measured [Ca2+]i changes in fura-2-loaded
slices in situ (Figure 10A). Spinal slices were serially stim-
ulated with 100 μM NMDA, 100 μM ATP, and 100 μM
NMDA+100  μM ATP. To prevent the refractoriness of
[Ca2+]i responses to repeated stimulation by ATP, we stim-
ulated the slices at more than 30-min intervals and con-
firmed the [Ca2+]i increase caused by repeated stimulation
with 100 μM ATP (data not shown). Figure 10B–D shows
representative traces of the [Ca2+]i change in the superfi-
cial and deeper layers of the spinal cord. NMDA alone
induced a rapid and transient [Ca2+]i increase and the
increase was higher in the deeper layer than in the super-
ficial layer (Figure 10B). On the other hand, ATP alone
also increased [Ca2+]i in the superficial layer rather than in
the deeper layer (Figure 10C). When the spinal slice was
Figure 5
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Involvement of cAMP in ATP-induced nNOSNT-YFP translo- cation Figure 5
Involvement of cAMP in ATP-induced nNOSNT-YFP 
translocation. A. Effect of ATP on cAMP production in 
NGF-differentiated PC12 cells. The cells (1 × 104 cells/well) 
in 24-well plates were incubated for 15 min without or with 
100 μM NMDA, 100 μM ATP or 1 nM PACAP in HBS con-
taining 0.5 mM iso-butyl-1-methylxanthine. The cAMP con-
tent in the cells was measured by using the cAMP assay kit as 
described in "Methods." Data are presented as the mean ± 
SEM (n = 4–7). **p < 0.01 compared with vehicle. B. Effect of 
permeable cAMP and cGMP analogues on nNOSNT-YFP 
translocation. After a 30-min incubation of NGF-differenti-
ated PC12N cells with vehicle, 500 μM 8-Br-cAMP or 500 
μM 8-Br-cGMP in the presence of 10 μM forskolin and 100 
μM NMDA, the translocation of nNOSNT-YFP was quanti-
fied as described in the legend for Figure 1B. Data are pre-
sented as the mean ± SEM (n = 4). *p < 0.05 compared with 
vehicle.Molecular Pain 2009, 5:40 http://www.molecularpain.com/content/5/1/40
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simultaneously stimulated by NMDA and ATP, the [Ca2+]i
increase was enhanced and prolonged both in the superfi-
cial layer and deeper layers (Figure 10D).
Effect on P2X3 antagonist on NO formation in the spinal 
cord of neuropathic pain model mice
The purinergic receptors in the spinal cord are shown to
be involved in neuropathic pain. We previously showed
that the increase in nNOS activity in the superficial dorsal
horn of the spinal cord reflects a neuropathic pain state
even 1 week after nerve injury [20]. To study whether ATP
was involved in neuropathic pain by nNOS activation, we
directly examined the effect of A-317491 on nNOS activa-
tion in neuropathic pain model mice using the fluorescent
NO indicator DAR-4M (Figure 11A). To avoid endog-
enous NO production and depletion of L-arginine, a sub-
strate of NOS, in the spinal cord during preparation and
loading DRA-4M, 1 mM L-NAME was added to the solu-
tion. When L-NAME in a Krebs solution was replaced by 1
mM L-arginine, the fluorescence intensity gradually
increased over 30 min in the dorsal horn in the lumbar
spinal slice prepared from mice 7 days after left L5 spinal
nerve transection. The increase was more prominent in
the superficial layer of the ipsilateral side than of the con-
tralateral side (Figure 11B and 11C). These increases in the
ipsilateral and contralateral sides were blocked by the
addition of A-317491 and resumed by its washout (Figure
11D).
Discussion
nNOS translocation by ATP
NO is well known to be implicated in nociceptive process-
ing in the spinal cord [17]. Based on the results of a study
using mice lacking the PACAP gene [21], we previously
suggested that PACAP is a key molecule of pain hypersen-
sitivity that acts by promoting the functional coupling of
nNOS to NMDA receptors. To address this suggestion, we
recently established a fluorescence imaging system for
Figure 6
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Signal pathways coupled to the ATP-induced nNOSNT-YFP  translocation Figure 6
Signal pathways coupled to the ATP-induced 
nNOSNT-YFP translocation. Effect of kinase inhibitors 
on the translocation of nNOSNT-YFP induced by NMDA, 
forskolin, and ATP. After a 30-min incubation of NGF-differ-
entiated PC12N cells with vehicle or with 100 μM NMDA, 
100 μM ATP, and 10 μM forskolin (FK) in the presence of 0.1 
μM calphostin C (Cal C), 1 μM KN-62, 1 μM PP2, 50 nM H-
89, 25 μM LY294002 (LY), 25 μM PD98059 (PD), 20 μM 
SB203580 (SB) or 25 μM roscovitine (RV), the translocation 
of nNOSNT-YFP was observed by confocal microscopy and 
quantified as described in the legend for Figure 1B. Data are 
presented as the mean ± SEM (n = 4). *p < 0.05 compared 
with vehicle; #p < 0.05 compared with NMDA, ATP, and FK.Molecular Pain 2009, 5:40 http://www.molecularpain.com/content/5/1/40
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examining nNOS translocation in PC12N cells and dem-
onstrated that the synergism of PACAP and NMDA was
critical for the translocation and activation of nNOS
through PKA, PKC, and Src kinase via PACAP receptor 1
and NMDA receptors [22]. Purinergic signaling is
involved in long-term inflammatory and neuropathic
pain as well as in acute pain [1,2] and ATP increases the
intracellular Ca2+ level in differentiated PC12 cells [26].
Different from the synergism of PACAP and NMDA, ATP
and NMDA could not translocate nNOSNT-YFP in PC12N
cells (Figure 1). This can be explained by the difference in
the ability of cAMP formation between PACAP and ATP
(Figure 5A). Therefore nNOS was translocated by ATP and
NMDA in the presence of forskolin (Figure 1B) or the
membrane-permeable cAMP analogue 8-Br-cAMP (Figure
5B). As observed in our recent study [22], nNOSNT-YFP
was localized to the membrane in 10–12% of the cells
before stimulation and maximally in 25–30% of the cells
mRNA expression of purinergic receptors in PC12N cells  and spinal cord Figure 7
mRNA expression of purinergic receptors in PC12N 
cells and spinal cord. PC12N cells were incubated without 
(-) or with (+) 50 ng/ml NGF for 5 days. Total RNA was 
extracted from the cells and the spinal cord and subjected to 
RT-PCR using the primers shown in Table 1. PCR products 
were analyzed by 2% agarose gel electrophoresis and stained 
with ethidium bromide. β-Actin and G3PDH were used for 
PC12N cells and for the spinal cord as the control and total 
RNA without RT was used as negative control.
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Effect of ATP and UTP on intracellular Ca2+ concentration  ([Ca2+]i) in spinal neurons Figure 8
Effect of ATP and UTP on intracellular Ca2+ concen-
tration ([Ca2+]i) in spinal neurons. A-C. Increase in 
[Ca2+]i by ATP in spinal neurons. Bright-field photomicro-
graph of cultured spinal neurons (A), fluorescence image of 
fura-2-loaded neurons excited at 340 nm (B), and ATP (10 
μM)-evoked [Ca2+]i changes in spinal neurons shown in pseu-
docolor as the ratio of fura-2 fluorescence intensity at 340/
380 nm (C). Scale bars, 50 μm. D, E. Representative traces 
of [Ca2+]i changes in single spinal neurons by ATP and UTP. 
Spinal neurons in the same field showed phasic (red) and 
tonic (blue) responses by 10 μM ATP (D) and 10 μM UTP 
(E). F, G. Distribution of [Ca2+]i responses of individual spi-
nal neurons to ATP and UTP. Fura-2-loaded spinal neurons 
were sequentially stimulated with the indicated concentra-
tions of ATP () and UTP (▲) in HBS, after which the peak 
levels of [Ca2+]i in single neurons were plotted at each con-
centration. Total 177 and 143 cells of 3 independent primary 
cultures were measured for ATP and UTP, respectively, and 
about 90% of the cells responded to ATP and UTP at 100 
μM.
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after the stimulation with 100 μM NMDA and 1 nM
PACAP. Since nNOSNT-YFP was over-expressed in PC12N
cells, the reason that the maximum translocation was at
most 25–30% of the cells might be ascribed to the nature
of nNOS translocation by forming a tertiary complex with
endogenous PSD-95 and NMDA receptors on the mem-
brane. In fact, a nNOSNT-YFP mutant lacking the β-finger
of the PDZ domain of nNOS was scarcely localized to the
membrane before stimulation; and the translocation to
the membrane was not increased by stimulation with
NMDA and PACAP. Furthermore, NO formation by
PACAP and NMDA was markedly attenuated in PC12N
cells, probably because over-expressed nNOSNT-YFP
competed with endogenous nNOS for forming the tertiary
complex on the membrane. Consistent with our recent
findings [22], the inhibitors of PKA, PKC, and Src kinase
blocked the enhancement of nNOSNT-YFP translocation
by ATP, forskolin, and NMDA (Figure 6A). Although P2X
and P2Y receptors activate several signaling pathways, the
inhibitors of other kinases failed to block the transloca-
tion of nNOSNT-YFP (Figure 6B). The present study
extended our recent studies by use of the fluorescence
imaging system and confirmed that the activation of Ca2+/
PKC and cAMP/PKA pathways is necessary and sufficient
for nNOS translocation in the presence of NMDA.
Characterization of purinergic receptors involved in nNOS 
translocation
ATP acts via various subtypes of ionotropic P2X receptors
and/or metabotropic P2Y receptors. The translocation of
nNOSNT-YFP by ATP was completely blocked by the non-
selective P2 receptor antagonist suramin and significantly
reduced by the P2X antagonist PPADS or the P2Y antago-
nist RB-2 (Figure 2). Conversely, 2-MeSATP, a P2X recep-
tor agonist or UTP, a P2Y2 and P2Y4 receptor agonist,
stimulated the translocation of nNOSNT-YFP to the
plasma membrane (Figure 3A). However, the increase in
the translocation of nNOSNT-YFP by 2-MeSATP or UTP
was not as great as that obtained with ATP itself. Co-stim-
ulation with 2-MeSATP and UTP increased the transloca-
tion of nNOSNT-YFP in a concentration-dependent
manner, with the increase being comparable to that
obtained with ATP and with similar EC50 values (Figure
3B). ATP, 2-MeSATP, and UTP induced the increase in
[Ca2+]i with EC50 values of 3.5, 10.8, and 2.84 μM, respec-
tively, in PC12N cells (Figure 4A); and ATP could increase
the [Ca2+]i in the absence of extracellular Ca2+(Figure 4B),
demonstrating that P2Y receptors as well as P2X receptors
were involved in the increase in the [Ca2+]i of PC12N
cells. Furthermore, it is intriguing that, whereas the non-
selective P2 receptor antagonist suramin fully suppressed
the ATP-induced increase in [Ca2+]i, PPADS and RB-2
reduced it only partially (Figure 4C). Consistent with the
Characterization of [Ca2+]i responses to ATP and UTP in cultured spinal neurons Figure 9
Characterization of [Ca2+]i responses to ATP and UTP in cultured spinal neurons. A. Concentration dependency 
of [Ca2+]i increase elicited by ATP () or UTP (▲) in primary cultured spinal neurons. B. Effect of P2 antagonists on ATP-
evoked [Ca2+]i increase in spinal neurons. Fura-2-loaded spinal neurons were sequentially stimulated with 1 μM ATP, 1 μM 
ATP with 100 μM suramin, 100 μM RB-2 or 10 μM A-317491, and then 1 μM ATP in HBS at more than 30-min periods for 
washing between stimulation, fluorescence images were taken at 5 sec intervals. Neurons that the ATP-evoked [Ca2+]i 
increase was considerably reduced were taken as antagonized and expressed as % of ATP-responsive cells (54 for suramin, 117 
for RB-2, and 118 for A-317491).
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results of a previous study [26], P2X1, P2X3, and P2X4
mRNAs were detected by RT-PCR in both undifferentiated
and NGF-differentiated PC12 cells; and P2X6 mRNA was
detected in NGF-differentiated PC12 cells (Figure 7).
Since P2X2 receptors were cloned from NGF-differentiated
PC12 cells [27], P2X receptors except for P2X7 are present
in NGF-differentiated PC12 cells. As for metabotropic P2Y
receptors, besides P2Y12 receptors that couple to Gi/o, the
other P2Y receptors P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 are
coupled to the Gq/11 proteins, leading to stimulation of
phosphoinositide metabolism, release of intracellular
Ca2+ stores and activation of PKC. P2Y2, P2Y4, and P2Y6
mRNAs were found in both undifferentiated and NGF-dif-
ferentiated PC12 cells. Since the P2Y6 receptor was not
activated by UTP, ATP and UTP may act on P2Y2 and P2Y4
receptors in NGF-differentiated PC12N cells. Arslan et al.
extensively characterized Ca2+ responses in PC12 cells and
suggested that P2X2/P2X2b, P2X4, and P2Y2 receptors con-
tribute to the ATP-induced [Ca2+]i increase in NGF-differ-
entiated PC12 cells [26]. Thus the presence of multiple
P2X and P2Y receptors in PC12 cells suggests that several
P2 receptor subtypes are involved in the increase in
[Ca2+]i and nNOS translocation and that the effects of
ATP on them seem to be additive.
Like PC12 cells, many P2X and P2Y receptors mRNAs
were detected by RT-PCR in the spinal cord (Figure 7). To
clarify the involvement of P2 receptors in nNOS translo-
cation in the spinal cord, we examined the effect of ATP
and UTP on [Ca2+]i in primary cultured spinal neurons.
While ATP and UTP increased the magnitude of [Ca2+]i
levels in a concentration-dependent manner, ATP was
more potent than UTP (Figure 9A), suggesting that both
P2X and P2Y receptors are involved in [Ca2+]i changes by
Figure 10
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Enhancement of NMDA-evoked [Ca2+]i increase by ATP in  the spinal cord Figure 10
Enhancement of NMDA-evoked [Ca2+]i increase by 
ATP in the spinal cord. A. Fluorescence image of a trans-
verse section of fura-2-loaded L5 spinal cord excited at 340 
nm. Areas surrounded by blue and red lines depict the 
regions to monitor fluorescence images of the dorsal horn. 
B-D represent typical traces of two regions showing the 
enhancement and prolongation of NMDA-evoked [Ca2+]i 
increase by ATP. The slice was serially stimulated by 100 μM 
NMDA (B), 100 μM ATP (C), and 100 μM NMDA and 100 
μM ATP (D). Between stimulation, the spinal slice was per-
fused by the Krebs solution for more than 30 min. [Ca2+]i 
changes in spinal slices were fluorometrically monitored at 5-
s intervals. [Ca2+]i changes are expressed as a ratio of fluo-
rescence emission intensity excited at 340/380 nm. Fluores-
cence images (i)-(ix) are shown in pseudocolour as ratio 
images at the indicated point on [Ca2+]i traces (B-D). Similar 
results were obtained with 10 slices prepared from 5 mice. 
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ATP in the spinal cord. This notion was supported by the
effect of antagonists on the ATP-evoked [Ca2+]i responses
(Figure 9B). While the P2Y receptor antagonist RB-2
inhibited 41%, the non-selective P2 receptor antagonist
suramin reduced the increase in 78% of the cells respon-
sive to 1 μM ATP. Interestingly, A-317491, a selective P2X3
antagonist, reduced only 6.8% of the ATP-responsive
cells. These results are consistent with the previous studies
that P2X3 receptors are expressed in DRG neurons and are
transported to the central process in the spinal cord
[28,29].
Significance of NO formation by ATP in nociceptive 
transmission
There is growing evidence that purinergic receptors in the
central and peripheral nervous systems are involved in
modification of pain sensation [1,2]. NO production fol-
lowing activation of P2 receptors has been shown to
exhibit both anti-nociceptive and pro-nociceptive effects.
The present study showed that ATP increased the translo-
cation of nNOSNT-YFP in PC12N cells in the presence of
NMDA and forskolin, suggesting the generalization that
the simultaneous activation of PKA, PKC, and Src-family
kinase is essential for the translocation of nNOSNT-YFP to
the membrane. Although mechanisms of synergism of
ATP and NMDA for nNOS translocation (Figure 2) remain
to be clarified, the [Ca2+]i increase was enhanced and pro-
longed by simultaneous stimulation of NMDA and ATP
both in the superficial layer and deeper layers of the spinal
cord in situ (Figure 10B–D) In behavioral studies, platelet-
activating factor-evoked tactile allodynia is mediated by
ATP and the subsequent NMDA and NO cascade through
capsaicin-sensitive fibers [30]. PPADS reduces pain-
related behaviors by inhibiting the increased activity of
the NO/NOS system in a neuropathic pain model [31]
Inoue's group recently showed that mice lacking all iso-
forms of NOS displayed a reduction in nerve injury-
induced neuropathic pain and exhibited a reduction in
microglia activation in the spinal cord [32]. We previously
showed that the increase in nNOS activity in the superfi-
cial dorsal horn of the spinal cord reflects a neuropathic
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Effect of A-317491 on NO production in the spinal 
cord 7 days after L5 spinal nerve transection. A. Fluo-
rescence image of a transverse section of DRA-4M-loaded L5 
spinal cord excited at 540 nm. Areas surrounded by red and 
blue lines depict the regions to monitor fluorescence of the 
dorsal horn in the sides ipsilateral and contralateral to L5 spi-
nal nerve transection. B-D. Inhibition of NO formation by A-
317491 in the dorsal horn of neuropathic pain model mice. 
Spinal slices were prepared from the L5 segment of neuro-
pathic pain model mice 7 days after L5 spinal nerve transec-
tion. Fluorescence imaging for NO was obtained in the spinal 
slice loaded with DAR-4M and images were taken at 5-s 
intervals as described in "Methods". B shows representative 
traces of inhibition NO formation by A-317491 in the spinal 
slice prepared from neuropathic pain model mice. Underlines 
indicate the presence of 10 μM A-317491 and 1 mM L-
arginine in the Krebs buffer. C, D. Fluorescence images of 
DAR-4M-loaded spinal cord at (C, an arrow) and 25 min after 
(D) the replacement of 1 mM L-NAME with 1 mM L-
arginine. Fluorescence images are shown in pseudocolour as 
ratio images on the basis of the initial intensity at the start of 
measurement. Similar results were obtained with 5 slices of 5 
animals. Bar = 500 μm.Molecular Pain 2009, 5:40 http://www.molecularpain.com/content/5/1/40
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pain state even 1 week after nerve injury [20] and that this
nNOS activation may be reversibly regulated by the trans-
location of nNOS from the cytosol to the plasma mem-
brane in the presence of NMDA and PACAP [21].
Consistent with our previous study [20], NO formation in
the dorsal horn was more prominent in the ipsilateral side
to L5-spinal nerve transection 7 days after operation and
this NO formation was markedly blocked by A-317491
(Figure 11). Thus the present study also demonstrates that
ATP might be involved in long-term neuropathic pain by
promoting the functional coupling of nNOS to NMDA
receptors under conditions in which neuromodulators
such as prostaglandin E2 that couple to the cAMP/PKA
pathway are released by continuous noxious inputs from
the periphery. Since the stimulation of a single neuron or
glia may activate multiple networks, a concomitant stim-
ulation of facilitatory and inhibitory circuits as a result of
ATP release is possible.
Conclusion
In the present study, we demonstrated that ATP could
translocate nNOS from the cytosol to the plasma mem-
brane in the presence of NMDA and forskolin by using a
fluorescence imaging system. Moreover, the translocation
of nNOSNT-YFP to the plasma membrane by ATP was
additively mediated by PKC via activation of P2X and P2Y
receptors. In a neuropathic pain model, nNOS was in an
activated state, which was blocked by the P2X3/P2X2/
3antagonist. The present study suggests that nNOS trans-
location may be an action mechanism of ATP in nociep-
tive processing in the spinal cord.
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